Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-05-22
1993-04-13
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514211, 514872, 540520, 546 99, 546100, C07D47108, A61K 3155, A61K 31455
Patent
active
052023338
ABSTRACT:
The present invention is directed to 5-HT.sub.3 receptor antagonist compounds of formula I: ##STR1## in which the dashed line denotes an optional double bond;
REFERENCES:
patent: 3341528 (1967-09-01), Shavel, Jr.
patent: 3896132 (1975-07-01), Bernauer
patent: 4309543 (1982-01-01), Keeley
patent: 4571396 (1986-01-01), Hutt
patent: 4959367 (1990-09-01), King et al.
Reynolds, J. C. 1989, Prokinetic Agents: A Key in the Future of Gastroenterology, Gastroenterology Clinics of North America, 18:437-457.
1989, Drugs Acting on 5-Hydroxytryptamine Receptors, The Lancet, pp. 717-719.
Scholtysik, G. 1988, 5-Hydroxytryptamine Antagonist ICS 205-930 Blocks Cardiac Potassium, Sodium and Calcium Channels, J. of Pharmacol. Exp. Ther. 245, 3:773-778.
King et al. 1990, Benzotriazinones as "Virtual Ring" Mimics of o-Methoxybenzamides: Novel and Potent 5-HT.sub.3 Receptor Antagonists, J. Med. Chem. 33:2942-2944.
Peatfield, R. 1988, Drugs and the treatment of Migraine, Trends Pharmacol. Sci. 9:141-145.
Komatsu et al. 1978, Chem. Abs. 89:100352x.
Hibert et al. 1988, Preparation and testing of 4-(2-pyrimidinyl)-1-piperazinepyrimidinediones and -oxazinones as minor tranquilizers, Chem. Abs. 108:221716p.
Berger Jacob
Clark Robin D.
Eglen Richard M.
Smith William L.
Weinhardt Klaus K.
Berch Mark L.
Freyberg Derek P.
Montgomery Wayne W.
Moran Tom M.
Syntex (U.S.A.) Inc.
LandOfFree
Tricyclic 5-HT.sub.3 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic 5-HT.sub.3 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic 5-HT.sub.3 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1155622